🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New Cell: Evidence to support D614 has become the dominant pandemic variant of #SARSCoV2 *and* that it is associated w/ higher viral loads, grows to higher titers cell.com/action/showPdf…

Marie Curie died of aplastic anaemia on 4 July 1934, a result of years of exposure to radiation through her work. Even today her laboratory notebook from 1899-1902, is radioactive and will be for 1,500 years. #NobelPrize

Aged 23, before she’d even earned her PhD, Carol Greider made her #NobelPrize discovery. Along with laureate Elizabeth Blackburn she discovered telomerase. At each end of a chromosome lies a protective "cap" called a telomere – telomerase is the enzyme that creates it.

I like this Figure published in "A brief history of human disease genetics" by Melina Claussnitzer, Ph.D. and colleagues - how can reviewers still run around today and claim that GWAS "did not work"? nature.com/articles/s4158…

Now published !

Join IARC as an early career scientist and become a member of ecsa_iarc !

science.sciencemag.org/content/370/65…

science.sciencemag.org/content/370/65…

A Visiting Scientist opportunity is available to help develop IARC Handbook Vol 19 on #OralCancer prevention. The ideal candidate will have exp in conducting systematic reviews or bibliographic reviews & epidemiology of oral cancer prevention. Interested? iarc.fr/wp-content/upl…

Great Mentor

Successful CRISPR-Cas9-based gene editing therapy for sickle cell disease and ß-thalassemia by international team led by Selim Corbacioglu (Regensburg) reported in the NEJM (nejm.org/doi/pdf/10.105…). Major accomplishment just few days before the CRISPR-Cas9 Nobel ceremony.

Exciting new work from @RuiBeneditoCNIC lab published in nature extending and revising the role of Notch signaling during arterialization (nature.com/articles/s4158…).

Am I angry at the #COVID19 vaccine #inequity? No. Am I disappointed? NO! Well.. no more than I'm at all other #vaccine / #globalhealth inequities. If this is all new to you, you have missed out on the centuries of inequity/discrimination entrenched in so called "global" health.

We are pleased to announce the launch of the following special issue Frontiers in molecular biosciences journal. Please submit your articles related to Molecular Biomarkers for the Diagnosis, Prognosis, and Risk Prediction of Cancer frontiersin.org/research-topic…

You know those nightmares when you want/need to scream but can't? Your body's paralyzed? Thats how I have been constantly feeling about #vaccineINEquity. The North has shut us down. No matter how much we try, write open letters, tweet, they can't hear us. Our voices don't exist.

At last, it is online. We described the rise of B.1.351 in #Bangladesh with our sequencing data Child Health Research Foundation (CHRF) Special thanks to Senjuti Saha, PhD | সেঁজুতি সাহা & Samir K Saha for keep trusting our genomics team. Yogesh Hooda Mohammad Sajib Roly Malaker Sharmistha Goswami Shuborno Islam gh.bmj.com/content/6/5/e0…

Dr Basu shared the #Bangladesh🇧🇩 experience to improve #cervical & #breast #cancerscreening in pandeminc time: ▶️Leveraging the investment made to improve the HIMS #DHIS2 ▶️Prioritize #cancerscreening activities ▶️protocol modified to include "#screen & #treat" IARC #IARCWCR

Daniel Middleton and Ismail Hosen will use an Early Detection and Diagnosis Primer Award to validate the use of non-invasive urine-based molecular early detection markers using DNA samples from people of Bangladeshi origin. Dan Middleton | Ismail Hosen | Queen's University Belfast 🎓 |

Delighted to be part of this important project. Many thanks to the partners and collaborators. Thank you Science and Innovation at Cancer Research UK

Thanks Queen's University Belfast 🎓 for highlighting this exciting #CRUKfunded collaboration with Ismail Hosen Florence Le Calvez-Kelm Michael Watts. We are happy to have started the project! Science and Innovation at Cancer Research UK